Skip to main content
. 2022 May 17;71(2):239–241. doi: 10.1016/j.jadohealth.2022.03.015

Figure 1.

Figure 1

Monthly rate of buprenorphine prescriptions by insurance status per 1,000 population before and during the COVID-19 pandemic: (A) ages 18–24 and (B) ages 25–29.